Growth of dislocation-free ZnSe single crystal by CVT method

Autor: Fujiwara, S. ^*, Namikawa, Y., Irikura, M., Matsumoto, K., Kotani, T., Nakamura, T.

Publikováno v: In Journal of Crystal Growth 2000 219(4):353-360

Development of a panchromatic photosensitizer and its application to photocatalytic CO 2 reduction.

Autor: Irikura M; Department of Chemistry, School of Science, Tokyo Institute of Technology O-okayama 2-12-1-NE-1, Meguro-ku Tokyo 152-8550 Japan tamaki@chem.titech.ac.jp ishitani@chem.titech.ac.jp., Tamaki Y; Department of Chemistry, School of Science, Tokyo Institute of Technology O-okayama 2-12-1-NE-1, Meguro-ku Tokyo 152-8550 Japan tamaki@chem.titech.ac.jp ishitani@chem.titech.ac.jp., Ishitani O; Department of Chemistry, School of Science, Tokyo Institute of Technology O-okayama 2-12-1-NE-1, Meguro-ku Tokyo 152-8550 Japan tamaki@chem.titech.ac.jp ishitani@chem.titech.ac.jp.

Publikováno v: Chemical science [Chem Sci] 2021 Sep 28; Vol. 12 (41), pp. 13888-13896. Date of Electronic Publication: 2021 Sep 28 (Print Publication: 2021).

Correction to: Awareness and current implementation of drug dosage adjustment by pharmacists in patients with chronic kidney disease in Japan: a web-based survey.

Autor: Kondo Y; Department of Clinical Chemistry and Informatics, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan. ykondo@kumamoto-u.ac.jp.; Minaminihon Pharmaceutical Center, 5-15-1 Taniyama-chuo, Kagoshima, 891-0141, Japan. ykondo@kumamoto-u.ac.jp., Ishitsuka Y; Department of Clinical Chemistry and Informatics, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan., Shigemori E; Minaminihon Pharmaceutical Center, 5-15-1 Taniyama-chuo, Kagoshima, 891-0141, Japan., Irikura M; Laboratory of Evidence-Based Pharmacotherapy, College of Pharmaceutical Sciences, Daiichi University, 22-1 Tamagawa-cho, Minami-ku, Fukuoka, 815-8511, Japan., Kadowaki D; Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan.; Center for Clinical Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan., Hirata S; Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan.; Center for Clinical Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan., Maemura T; Minaminihon Pharmaceutical Center, 5-15-1 Taniyama-chuo, Kagoshima, 891-0141, Japan., Irie T; Department of Clinical Chemistry and Informatics, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan.; Center for Clinical Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan.

Publikováno v: BMC health services research [BMC Health Serv Res] 2021 Jun 29; Vol. 21 (1), pp. 617. Date of Electronic Publication: 2021 Jun 29.

A homogeneous assay to determine high-density lipoprotein subclass cholesterol in serum.

Autor: Matsushima-Nagata K; Kumamoto Health Science University, Kumamoto, Japan., Sugiuchi H; Kumamoto Health Science University, Kumamoto, Japan. Electronic address: sugiuchi@kumamoto-hsu.ac.jp., Anraku K; Kumamoto Health Science University, Kumamoto, Japan., Takao T; Department of Clinical Chemistry and Informatics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Kondo Y; Department of Clinical Chemistry and Informatics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Ishitsuka Y; Department of Clinical Chemistry and Informatics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Irikura M; Laboratory of Evidence-Based Pharmacotherapy, Daiichi University of Pharmacy, Fukuoka, Japan., Irie T; Department of Clinical Chemistry and Informatics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Matsumura T; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan., Araki E; Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan., Sumida M; Research Center, Hitachi Chemical Diagnostics Systems Co., Ltd., Shizuoka, Japan., Katayama Y; Research Center, Hitachi Chemical Diagnostics Systems Co., Ltd., Shizuoka, Japan., Kayahara N; Hitachi Chemical Diagnostics Systems Co., Ltd., Tokyo, Japan.

Publikováno v: Analytical biochemistry [Anal Biochem] 2021 Jan 15; Vol. 613, pp. 114019. Date of Electronic Publication: 2020 Nov 12.

Comparison of quality of life and activity of daily living status of patients with myasthenia gravis treated with low-dose and high-dose prednisolone.

Autor: Katsuki M; Center of Pharmaceutical Care for Community Health, Daiichi University of Pharmacy, Fukuoka, Japan., Sugahara H; Laboratory of Evidence-Based Pharmacotherapy, Daiichi University of Pharmacy, Fukuoka, Japan., Kojima Y; Laboratory of Evidence-Based Pharmacotherapy, Daiichi University of Pharmacy, Fukuoka, Japan., Yamashita K; Laboratory of Evidence-Based Pharmacotherapy, Daiichi University of Pharmacy, Fukuoka, Japan., Moriuchi H; Center of Pharmaceutical Care for Community Health, Daiichi University of Pharmacy, Fukuoka, Japan., Kubota T; Center of Pharmaceutical Care for Community Health, Daiichi University of Pharmacy, Fukuoka, Japan., Masuda M; Department of Neurology, Tokyo Medical University, Tokyo, Japan., Irikura M; Laboratory of Evidence-Based Pharmacotherapy, Daiichi University of Pharmacy, Fukuoka, Japan.

Publikováno v: Neuro endocrinology letters [Neuro Endocrinol Lett] 2020 Oct; Vol. 41 (4), pp. 173-178.